VendorVigilance was built by a clinical QA professional who spent years managing the exact processes the platform supports. He partnered with two co-founders who have built and run SaaS products together for nearly two decades.
VendorVigilance is built and operated by Mayet, a software company specialising in the pharmaceutical and biotech industry.
Mayet built VendorVigilance for clinical trial sponsors who outsource activities to third-party service providers and need structured, GxP-compliant oversight of those vendor relationships.
Tom Lazenby spent his career inside the clinical trial oversight system: monitor, QA manager, QA programme lead.
At every organisation he joined, he found himself building or rebuilding systems, but when it came to vendor management there was no true solution to this complex process.
VendorVigilance exists because Tom built the product he needed and couldn't find. He partnered with Neyts Zupan and Dejan Murko, software entrepreneurs with nineteen years of shared experience building and operating SaaS products, to make it real.
Together they founded Mayet in 2023.
Clinical trials quality assurance professional turned software founder.
Over a decade managing vendor audit programmes, quality oversight, and regulatory inspections at GSK, UCL Clinical Trials Unit, and Imperial College London.
Single point of accountability for quality oversight across fifty-plus studies at GSK.
Every workflow in VendorVigilance reflects how clinical QA professionals view vendor management best practices, because Tom has done the work.
Software engineer and technical leader with over twenty years of professional development experience.
Co-founded Niteo with Dejan in 2007, a remote-first SaaS company they have built and operated together for nineteen years.
Co-founded Pareto Security, a device compliance tool. International conference speaker on Python, web development, and engineering productivity.
When clients ask how VendorVigilance handles encryption, access control, or disaster recovery, the answers come from a CTO who has built a security product.
Product leader and SaaS entrepreneur.
Co-founded Niteo with Neyts in 2007 and has been his business partner for nineteen years, through Niteo, Pareto Security, and now Mayet.
Led products that collectively served over 10,000 customers with successful exits.
Active SaaS investor with perspective on how software companies are evaluated, acquired, and sustained.
His role at Mayet: translate domain expertise and client insights into a product that is intuitive and scalable.
Mayet's advisory board brings over 120 years of combined experience in pharmaceutical and clinical research.
Former CEO and CCO with over 30 years in pharma, biotech, and CRO environments.
Executive VP Global Quality with over 30 years in clinical research.
Clinical Research Training Consultant with over 30 years in clinical trials.
Pharmaceutical Quality Consultant and former VP R&D Quality at GSK with over 30 years in medicines development.
Mayet partners with DQA, an independent quality assurance consultancy specialising in healthcare, biotech, and medical devices. DQA provides compliance and validation support to both Mayet and its clients, so regulatory requirements are addressed from the earliest stages of product development.
PHARMASEAL International Ltd, established in 2016, builds the Engility® Trial Management platform: a unified, cloud-based suite that helps life science organisations run clinical trials with better collaboration, oversight, and productivity across clinical operations.
As an integration partner, PHARMASEAL connects Engility to VendorVigilance with purpose-built data flows, at a lower cost than bespoke integration work.
A one-hour walkthrough of how your vendors, studies and qualifications would look in VendorVigilance.
No commitment required.
